Comparative Transcriptomics Study of Curcumin and Conventional Therapies in Translocation, Clear Cell, and Papillary Renal Cell Carcinoma Subtypes
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136161 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Moses Owoicho Abah und 15 weiteren Autor:innen. Beteiligte Einrichtung: World-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, Moscow 19991, Russia. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Curcumin, Kidney Neoplasms, Transcriptome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Currently, there is no standard treatment for renal cell carcinoma (RCC) that is free of side effects and resistance. Additionally, limited information exists on how curcumin affects the gene expression profiles of patients with translocation renal cell carcinoma (tRCC) and papillary renal cell carcinoma (pRCC). The pathways responsible for metastasis in tRCC are still not well understood, and there is no established treatment or reliable biomarker to predict outcomes for metastatic tRCC. Primary clinical data from patients were retrieved from the TCGA database and analyzed using cBioPortal, stitch, string, R and Python. Various analyses were performed, including differential gene expression, protein-protein interaction (PPI) network analysis, drug-targeted gene analysis, gene ontology (GO), enrichment analyses, and systematic searches to assess the impact of curcumin on the transcriptomic profiles of tRCC, pRCC, and clear cell renal cell carcinoma (ccRCC). No significant impact of sensitive genes on survival in KIRC and KIRP was found, though a trend suggested they may delay disease progression. The combination of curcumin with sunitinib showed promise in overcoming drug resistance in ccRCC by inducing ferroptosis, reducing iron, and increasing ADAMTS18 expression. This study, leveraging data from the TCGA database and other databases explored the impact of curcumin on transcriptomic profiles in tRCC, pRCC, and clear cell RCC (ccRCC). Gene analysis revealed immune and metabolic differences, with KIRC showing a stronger immune response. This study is the first to propose that future research into the miR-148/ADAMTS18 genes and the ferroptosis pathway in tRCC and pRCC could lead to the development of new therapies and the identification of novel therapeutic targets, potentially overcoming drug resistance and metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- World-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, Moscow 19991, Russia.
- Department of Cancer Bioinformatics and Molecular Biology, Royal Society of Clinical and Academic Researchers (ROSCAR) International, Abuja 900104, Nigeria.
- Medical Laboratory Science Department, Faculty of Health Science and Technology, College of Medicine, University of Nigeria, Enugu Campus, Enugu 410001, Nigeria.
- Department of Public Health, James Lind Institute, Rue de la Cité 1, 1204 Geneva, Switzerland.
- Department of General Medicine, I.M Sechenov First Moscow State Medical University, Moscow 19991, Russia.
ORCID-Profile: Moses Owoicho Abah, Deborah Oganya Ogenyi, Yvan Sinclair Ngaha Tchawe, Akaye Madu Pascal, Natalia M Nikitina, Onoja Solomon Oloche, Alexander S Rusanov, Varvara D Sanikovich, Yuliya N Pirogova
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Abah, M. O., Ogenyi, D. O., Zhilenkova, A. V., Essogmo, F. E., Uchendu, I. K., Tchawe, Y. S. N., Pascal, A. M., Nikitina, N. M., Oloche, O. S., Pavliv, M., Rusanov, A. S., Sanikovich, V. D., Pirogova, Y. N., Bagmet, L. N., Moiseeva, A. V., & Sekacheva, M. I. (2025). Comparative Transcriptomics Study of Curcumin and Conventional Therapies in Translocation, Clear Cell, and Papillary Renal Cell Carcinoma Subtypes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136161
Vancouver
Abah MO, Ogenyi DO, Zhilenkova AV, Essogmo FE, Uchendu IK, Tchawe YSN, et al. Comparative Transcriptomics Study of Curcumin and Conventional Therapies in Translocation, Clear Cell, and Papillary Renal Cell Carcinoma Subtypes. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136161
BibTeX
@article{Abah2025,
author = {Abah, Moses Owoicho and Ogenyi, Deborah Oganya and Zhilenkova, Angelina V and Essogmo, Freddy Elad and Uchendu, Ikenna Kingsley and Tchawe, Yvan Sinclair Ngaha and Pascal, Akaye Madu and Nikitina, Natalia M and Oloche, Onoja Solomon and Pavliv, Maria and Rusanov, Alexander S and Sanikovich, Varvara D and Pirogova, Yuliya N and Bagmet, Leonid N and Moiseeva, Aleksandra V and Sekacheva, Marina I},
title = {Comparative Transcriptomics Study of Curcumin and Conventional Therapies in Translocation, Clear Cell, and Papillary Renal Cell Carcinoma Subtypes},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136161}
}
EUVIMED